Cargando…

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

Detalles Bibliográficos
Autores principales:	Güney, Tekin, Can, Ferda, Akıncı, Sema, Soyer Kösemehmetoğlu, Özge, Dilek, İmdat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886268/ https://www.ncbi.nlm.nih.gov/pubmed/34886748 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0537

Ejemplares similares

Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020)

Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
por: Ruhe, Johannes, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021)

Dengue and Thrombotic Thrombocytopenic Purpura
por: Wiwanitkit, Viroj
Publicado: (2017)

BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
por: Ghosh, A. K., et al.
Publicado: (2022)

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
por: Arıkan, Fatma, et al.
Publicado: (2020)

Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient
por: Yoshida, Kikuaki, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Thrombotic Thrombocytopenic Purpura or Disseminated Intravascular Coagulation?
por: Pannu, Ashok Kumar, et al.
Publicado: (2017)

Recurrence of Thrombotic Thrombocytopenic Purpura After COVID-19 Vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Massive Platelet Clumping on Peripheral Blood Smear and Pseudothrombocytopenia in a Patient with COVID-19
por: Can, Ferda, et al.
Publicado: (2021)

Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
por: Fenoglio, Roberta, et al.
Publicado: (2022)

A case of thrombotic thrombocytopenic purpura in late pregnancy
por: Soe, Aye Min, et al.
Publicado: (2016)

Posterior Reversible Encephalopathy Syndrome in Thrombotic Thrombocytopenic Purpura
por: Bhat, Vivek, et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura as the initial presentation of COVID‐19
por: Beaulieu, Marie‐Claude, et al.
Publicado: (2021)

Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020)

Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023)

Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature
por: Buetler, Vanessa Alexandra, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's witness
por: Walia, Sandeep S., et al.
Publicado: (2011)

Tacrolimus associated thrombotic thrombocytopenic purpura (TTP) and stroke in the young
por: Maramattom, Boby Varkey, et al.
Publicado: (2015)

Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
por: Albiol, Nil, et al.
Publicado: (2020)

A case of thrombotic thrombocytopenic purpura associated with COVID-19
por: Nicolotti, Davide, et al.
Publicado: (2021)

COVID-19 and thrombotic thrombocytopenic purpura: A review of literature
por: Singh, Balraj, et al.
Publicado: (2021)

Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
por: Laghmouchi, Aicha, et al.
Publicado: (2021)

Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination
por: Schieppati, Francesca, et al.
Publicado: (2021)

Erratum: Immune-mediated thrombotic thrombocytopenic purpura following mRNA-based COVID-19 vaccine BNT162b2: Case report and mini-review of the literature
Publicado: (2023)

Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report
por: Ge, Hangping, et al.
Publicado: (2022)

Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
por: Lin, Hung-Chen, et al.
Publicado: (2023)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
por: Syed, Umer, et al.
Publicado: (2018)

Novel therapies in thrombotic thrombocytopenic purpura
por: Masias, Camila, et al.
Publicado: (2017)

Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis
por: Malik, Zohra R, et al.
Publicado: (2018)

Cardiac implications of thrombotic thrombocytopenic purpura
por: Wiernek, Szymon L, et al.
Publicado: (2018)

Ticagrelor-associated thrombotic thrombocytopenic purpura
por: Doğan, Ali, et al.
Publicado: (2017)

Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
por: Bukhari, Sumera, et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura secondary to Streptococcus
por: Morrin, M.J., et al.
Publicado: (2006)

Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kikve0uieiv7cic5plepvsf2ii